Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study - Summary - MDSpire

Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study

  • By

  • Oliver Kriege

  • Boris Böll

  • Nicole Brüder

  • Nicola Giesen

  • Julia Lanznaster

  • Susanne Mertins

  • Antrea Minti

  • Jan-Hendrik Naendrup

  • Martin Schmidt-Hieber

  • Ruth Seggewiss-Bernhardt

  • Philipp Weber

  • Kai Wille

  • Jens Panse

  • Marcus Hentrich

  • Enrico Schalk

  • July 10, 2026

Share

Objective:

To investigate whether a simulated intervention involving minimal shortening of central venous catheter (CVC) dwelling time in men results in a lower overall catheter-related bloodstream infection (oCRBSI) rate in patients with hematological and oncological diseases.

Approach:
  • Randomization: Patients were randomized using a web-based platform for randomization, stratified by center, into experimental (EXP-G) and control groups (CON-G) in a 1:1 ratio.
Key Findings:
  • The overall oCRBSI rate was 7.3% in the entire cohort, with similar rates in both EXP-G (7.3%) and CON-G (7.4%) (p = 0.85).
  • Median CVC dwelling time for men was 13 days in both groups.
  • No significant difference in neutropenia rates was observed between the EXP-G and CON-G (p = 0.45).
Interpretation:

The simulation of shortening CVC dwelling time did not lead to a significant reduction in oCRBSI rates among male patients (p = 0.85).

Limitations:
  • The study was based on registry data, which may limit the generalizability of the findings to broader populations.
  • The low event rate of CRBSI may affect the statistical power of the study, potentially limiting the ability to detect significant differences.
Conclusion:

The intervention of shortening CVC duration did not demonstrate a significant impact on reducing oCRBSI rates in male patients with hematological and oncological disorders.

Original Source(s)

Related Content